2016
DOI: 10.1016/j.bbagrm.2015.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(19 citation statements)
references
References 45 publications
1
18
0
Order By: Relevance
“…These gluconeogenic genes are mainly controlled by hepatocyte nuclear factor-4α (HNF4α), cAMP-response element-binding protein (CREB) and forkhead box O1 (FoxO1) transcription factors, PGC1α coactivator, and by GR; PPARα, LXRs, or SREBP-1c are dominant in regulation of lipid metabolism genes ( Miao et al, 2006 ; Oh et al, 2013 ; Gao et al, 2015 ). hCAR activation has previously been reported to suppress the expression of gluconeogenic enzymes G6Pase and PEPCK1 in primary human hepatocytes pre-treated with FSK ( Gao et al, 2015 ) and in mice under nutritional stress (high-fat diet, in leptin-deficient obese mice, under fasting conditions) ( Miao et al, 2006 ; Dong et al, 2009 ; Gao et al, 2009 ; Yarushkin et al, 2013 ; Yu et al, 2016 ). The regulation of the fatty acids and steroids synthetic enzymes HMGCS2 and FASN after treatment with the mCAR agonist TCPOBOP in mice after high- fat or 1% cholesterol diet has been confirmed several times ( Gao et al, 2009 ; Rezen et al, 2009 ).…”
Section: Discussionmentioning
confidence: 99%
“…These gluconeogenic genes are mainly controlled by hepatocyte nuclear factor-4α (HNF4α), cAMP-response element-binding protein (CREB) and forkhead box O1 (FoxO1) transcription factors, PGC1α coactivator, and by GR; PPARα, LXRs, or SREBP-1c are dominant in regulation of lipid metabolism genes ( Miao et al, 2006 ; Oh et al, 2013 ; Gao et al, 2015 ). hCAR activation has previously been reported to suppress the expression of gluconeogenic enzymes G6Pase and PEPCK1 in primary human hepatocytes pre-treated with FSK ( Gao et al, 2015 ) and in mice under nutritional stress (high-fat diet, in leptin-deficient obese mice, under fasting conditions) ( Miao et al, 2006 ; Dong et al, 2009 ; Gao et al, 2009 ; Yarushkin et al, 2013 ; Yu et al, 2016 ). The regulation of the fatty acids and steroids synthetic enzymes HMGCS2 and FASN after treatment with the mCAR agonist TCPOBOP in mice after high- fat or 1% cholesterol diet has been confirmed several times ( Gao et al, 2009 ; Rezen et al, 2009 ).…”
Section: Discussionmentioning
confidence: 99%
“…Mechanistically, CAR-mediated energy homeostasis appears to be involved in a combined repression of an array of genes associated with gluconeogenesis, fatty acid synthesis, and energy expenditure such as phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase), fatty acid synthase, and stearoyl-CoA desaturase-1 (Yu et al, 2016). This downregulation is involved in the prevention of the FOXO1 transcription factor from interacting with insulin response element binding sites located upstream of genes such as PEPCK1, G6Pase, and insulin-like growth factor-binding protein 1 (Kodama et al, 2004).…”
Section: Constitutive Androstane Receptormentioning
confidence: 99%
“…Activation of CAR in mice has been shown to mitigate hepatic steatosis, increase glucose tolerance and insulin sensitivity, and alleviate or prevent obesity in diabetic mouse models (Dong et al, 2009;Gao et al, 2009). CAR-mediated antilipogenic effects were also observed in hyperlipidemic HepG2 cell cultures treated with evodia alkaloids (Yu et al, 2016). Furthermore, the hormone irisin was recently identified as a direct target of CAR and protects HFD-induced obese mice through the CAR-irisin axis (Mo et al, 2016).…”
Section: Constitutive Androstane Receptormentioning
confidence: 99%
“…This interaction was demonstrated to result in a CAR-induced attenuation of FOXO target gene expression, such as of genes coding for gluconeogenesis enzymes, phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase (G6Pase), or the cyclin-dependent kinase inhibitor, p21, and also FOXO1 itself [27] . CAR-mediated suppression of FOXO1 (along with hepatocyte nuclear factor 4α, HNF4α) was suggested to be responsible for the anti-gluconeogenesis effects of certain alkaloids [28] . Similarly, PXR activation was shown to affect gluconeogenesis not only through FOXO1 inhibition but also through competition for PPARγ coactivator (PGC) 1α, a known coregulator of FOXOs as well as other transcriptional regulators, such as HNF4α (for review, see [29] ).…”
Section: Interactions Between Foxos and Xenosensorsmentioning
confidence: 99%